ClinicalTrials.Veeva

Menu

Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction (RESET)

University Hospital Basel logo

University Hospital Basel

Status

Completed

Conditions

Status Epilepticus
Refractory Status Epilepticus

Treatments

Other: Data collection

Study type

Observational

Funder types

Other

Identifiers

NCT04333082
2020-00538 me20Sutter;

Details and patient eligibility

About

This study is to investigate the effects of different treatment characteristics regarding the use of intravenous anesthetic drugs (IVADs) as a rescue treatment for refractory Status epilepticus (RSE) on course and outcome. A retrospective data extraction from the digital medical records, the electroencephalographic and microbiologic database of all consecutive adult patients with Status epilepticus (SE) admitted to the University Hospital Basel is undertaken.

Enrollment

147 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosed SE between 2005 and 2019 who have been treated at intensive care units (ICUs) of the University Hospital of Basel

Exclusion criteria

  • Patients with repetitive epileptic seizures not qualifying for SE or RSE
  • Patients with documented refusal of the general in-house consent

Trial contacts and locations

1

Loading...

Central trial contact

Raoul Sutter, PD Dr. med; Anja Rybitschka, Cand. med.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems